Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 4/20 | 0.55 |
| ▸ | DRD5 | P21918 | 4/20 | 0.55 |
| ▸ | DRD3 | P35462 | 4/20 | 0.55 |
| ▸ | HTR1A | P08908 | 1/20 | 0.55 |
| ▸ | HTR7 | P34969 | 2/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.54 |
| ▸ | ACHE | P22303 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30073106 | 0.83 | KDM4E (0.72) | DRD2DRD5DRD3HTR1AHTR7 | |
| SCHEMBL30073110 | 0.83 | KDM4E (0.72) | DRD2DRD5DRD3HTR1AHTR7 | |
| SCHEMBL29676790 | 0.78 | HTR7 (0.62) | DRD2DRD5DRD3HTR1AHTR7 | |
| SCHEMBL5659084 | 0.78 | ACHE (0.62) | DRD2DRD5DRD3HTR1AHTR7 | |
| Hydrochloric Acid SCHEMBL5658146 | 0.77 | ACHE (0.61) | DRD2DRD5DRD3HTR1AHTR7 | |
| SCHEMBL29802804 | 0.75 | DRD3 (0.67) | DRD2DRD5DRD3HTR1AHTR7 | |
| SCHEMBL29564155 | 0.75 | HTR1A (0.55) | HTR1A | |
| SCHEMBL20404 | 0.75 | HTR1A (0.55) | HTR1A | |
| SCHEMBL6716162 | 0.75 | DRD3 (0.69) | DRD2DRD5DRD3HTR1AHTR7 | |
| SCHEMBL8242914 | 0.73 | KDM4E (0.64) | DRD2DRD5DRD3HTR1AHTR7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9429568-B2 | Silaanthracene as a red and near infrared sensor and a method to manufacture such a sensor | BOARD OF TRUSTEES OF SOUTHERN ILLINOIS UNIVERSITY ON BEHALF OF SOUTHERN ILLINOIS UNIVERSITY CARBONDALE (US) | 2016-08-30 | — | — | US | disclosed |
| US-20150185209-A1 | BIOLOGICALLY ACTIVE COMPLEX AND ITS PREPARATION | SOUTHERN ILLINOIS UNIVERSITY CARBONDALE (US) | 2015-07-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150185209-A1 | BIOLOGICALLY ACTIVE COMPLEX AND ITS PREPARATION | PGLS, FOS, SPR | DRD2 4803/4885DRD5 4651/4885DRD3 4673/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.